TRETINOIN

TRETINOIN was reported 8222 times

TRETINOIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RETINOIC ACID SYNDROME 72 0.4186
1 ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME 78 0.3750
2 DIFFERENTIATION SYNDROME 233 0.3174
3 CONGENITAL KNEE DISLOCATION 9 0.2250
4 OVERLAP SYNDROME 92 0.1314
5 HAEMATOPOIETIC NEOPLASM 20 0.1064
6 HYPOCHOLESTEROLAEMIA 30 0.0850
7 BONE MARROW NECROSIS 18 0.0769
8 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 8 0.0656
9 MYELODYSPLASTIC SYNDROME TRANSFORMATION 29 0.0557
10 BLEPHAROSPASM 308 0.0489
11 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 27 0.0481
12 FACET JOINT SYNDROME 143 0.0439
13 LUPUS VULGARIS 55 0.0437
14 PERIPHERAL VENOUS DISEASE 165 0.0404
15 CHROMOSOMAL DELETION 6 0.0377
16 INFUSION SITE REACTION 111 0.0371
17 ACUTE PROMYELOCYTIC LEUKAEMIA 38 0.0370
18 ONYCHOMADESIS 155 0.0369
19 RHEUMATIC FEVER 164 0.0368
20 CENTRAL HYPOTHYROIDISM 12 0.0363
21 SCROTAL ULCER 8 0.0307
22 DISLOCATION OF VERTEBRA 67 0.0293
23 BENIGN INTRACRANIAL HYPERTENSION 34 0.0271
24 LARGE GRANULAR LYMPHOCYTOSIS 9 0.0268
25 BREAST CANCER STAGE III 171 0.0264
26 HYPERLEUKOCYTOSIS 23 0.0260
27 C-REACTIVE PROTEIN 24 0.0259
28 LEUKAEMIA RECURRENT 40 0.0236
29 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 166 0.0231
30 RETINITIS 39 0.0226
31 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 7 0.0221
32 DEEP VEIN THROMBOSIS POSTOPERATIVE 44 0.0220
33 DUODENAL ULCER PERFORATION 154 0.0207
34 CONGENITAL MUSCULOSKELETAL ANOMALY 9 0.0204
35 CHLOASMA 9 0.0194
36 IDIOPATHIC INTRACRANIAL HYPERTENSION 43 0.0191
37 SERUM FERRITIN ABNORMAL 6 0.0187
38 LIVE BIRTH 155 0.0185
39 LIP DRY 160 0.0176
40 MUSCLE INJURY 142 0.0171
41 FOLLICULITIS 176 0.0168
42 TINEA VERSICOLOUR 6 0.0167
43 APPLICATION SITE EXFOLIATION 68 0.0165
44 TASTE DISORDER 334 0.0164
45 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 33 0.0159
46 X-RAY ABNORMAL 28 0.0156
47 BACK INJURY 169 0.0155
48 CYTOGENETIC ABNORMALITY 17 0.0151
49 SWOLLEN JOINT COUNT INCREASED 46 0.0144
50 BURSITIS 175 0.0144
51 NAIL DISORDER 126 0.0144
52 CHLOROMA 6 0.0142
53 POLYARTERITIS NODOSA 8 0.0137
54 HYPERCHOLESTEROLAEMIA 131 0.0136
55 PEMPHIGUS 164 0.0131
56 WOUND INFECTION 143 0.0130
57 HELICOBACTER INFECTION 129 0.0125
58 PERICARDITIS 205 0.0122
59 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 8 0.0120
60 SYNOVITIS 205 0.0114
61 HAND DEFORMITY 147 0.0112
62 APPLICATION SITE DRYNESS 38 0.0112
63 IIIRD NERVE PARALYSIS 9 0.0111
64 XEROSIS 13 0.0105
65 JOINT RANGE OF MOTION DECREASED 138 0.0103
66 BONE EROSION 36 0.0102
67 EPILEPSY 309 0.0101
68 SIMPLE PARTIAL SEIZURES 8 0.0099
69 NORMAL NEWBORN 52 0.0096
70 SEROUS RETINAL DETACHMENT 8 0.0095
71 INTRACRANIAL PRESSURE INCREASED 53 0.0095
72 AXONAL NEUROPATHY 8 0.0092
73 MYOPERICARDITIS 7 0.0090
74 IRRITABLE BOWEL SYNDROME 191 0.0089
75 RHEUMATOID FACTOR POSITIVE 51 0.0088
76 SERONEGATIVE ARTHRITIS 10 0.0087
77 SKIN WRINKLING 23 0.0085
78 PORPHYRIA ACUTE 12 0.0084
79 PRODUCT ADMINISTRATION INTERRUPTED 65 0.0083
80 OBESITY 127 0.0080
81 GLOSSODYNIA 173 0.0077
82 WOUND 210 0.0075
83 SKIN TEXTURE ABNORMAL 7 0.0073
84 PUSTULAR PSORIASIS 25 0.0073
85 C-REACTIVE PROTEIN ABNORMAL 46 0.0072
86 APPLICATION SITE DISCOLOURATION 29 0.0071
87 VITH NERVE PARALYSIS 8 0.0070
88 BREAST CANCER STAGE II 57 0.0068
89 FIBROMYALGIA 165 0.0068
90 PRODUCT PHYSICAL CONSISTENCY ISSUE 37 0.0067
91 APPLICATION SITE PAPULES 7 0.0066
92 GRIP STRENGTH DECREASED 58 0.0066
93 CONTRAINDICATED PRODUCT ADMINISTERED 193 0.0064
94 HAEMORRHAGIC DIATHESIS 22 0.0062
95 PRODUCT LABEL CONFUSION 36 0.0062
96 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 40 0.0062
97 ACNE PUSTULAR 5 0.0061
98 ACUTE MYELOID LEUKAEMIA RECURRENT 13 0.0060
99 EXOSTOSIS 55 0.0060
100 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 14 0.0060
101 COELIAC DISEASE 59 0.0060
102 RASH VESICULAR 29 0.0060
103 FINGER DEFORMITY 28 0.0058
104 NIGHT SWEATS 185 0.0057
105 LIVER FUNCTION TEST INCREASED 123 0.0057
106 ONYCHOMYCOSIS 25 0.0057
107 RED BLOOD CELL SEDIMENTATION RATE INCREASED 63 0.0057
108 ACUTE MYELOID LEUKAEMIA 86 0.0055
109 AUTOIMMUNE DISORDER 53 0.0054
110 PAPILLOEDEMA 24 0.0053
111 ACNE CYSTIC 16 0.0053
112 TYPE 2 DIABETES MELLITUS 174 0.0052
113 SKIN WARM 30 0.0052
114 DYSPHORIA 26 0.0051
115 ISCHAEMIC HEPATITIS 7 0.0051
116 INFLAMMATORY BOWEL DISEASE 50 0.0051
117 LIVER INJURY 123 0.0050
118 PSORIATIC ARTHROPATHY 202 0.0050
119 PRE-EXISTING CONDITION IMPROVED 31 0.0050
120 SYSTEMIC LUPUS ERYTHEMATOSUS 171 0.0048
121 APPLICATION SITE SWELLING 24 0.0048
122 MATERNAL EXPOSURE TIMING UNSPECIFIED 18 0.0048
123 OSTEOARTHRITIS 202 0.0048
124 IMPAIRED HEALING 155 0.0047
125 GAIT INABILITY 152 0.0045
126 ARTHRITIS INFECTIVE 21 0.0045
127 JOINT DESTRUCTION 7 0.0045
128 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 6 0.0044
129 C-REACTIVE PROTEIN INCREASED 160 0.0044
130 NEUTROPENIC SEPSIS 31 0.0043
131 APPLICATION SITE INFLAMMATION 6 0.0043
132 GASTROOESOPHAGEAL REFLUX DISEASE 346 0.0043
133 MYELODYSPLASTIC SYNDROME 62 0.0043
134 DRUG TOLERANCE DECREASED 12 0.0043
135 BLOOD CHOLESTEROL INCREASED 198 0.0042
136 LYMPHOCYTOSIS 9 0.0042
137 THERAPEUTIC PRODUCT EFFECT DECREASED 186 0.0041
138 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 21 0.0041
139 BILIARY DYSKINESIA 7 0.0041
140 OBSTRUCTIVE SLEEP APNOEA SYNDROME 6 0.0041
141 SEBORRHOEA 15 0.0041
142 DARK CIRCLES UNDER EYES 6 0.0041
143 KIDNEY FIBROSIS 7 0.0040
144 TERMINAL INSOMNIA 7 0.0040
145 APPLICATION SITE ERYTHEMA 102 0.0039
146 MATERNAL EXPOSURE DURING PREGNANCY 346 0.0039
147 BLISTER 217 0.0039
148 APPLICATION SITE IRRITATION 48 0.0039
149 ACQUIRED GENE MUTATION 5 0.0038
150 NECK PAIN 211 0.0038
151 INFLAMMATION 194 0.0038
152 CHOLECYSTITIS CHRONIC 25 0.0037
153 CHEILITIS 20 0.0037
154 APPETITE DISORDER 24 0.0036
155 SKIN TIGHTNESS 17 0.0036
156 STEM CELL TRANSPLANT 9 0.0036
157 APPLICATION SITE PAIN 79 0.0036
158 DRUG INTOLERANCE 346 0.0036
159 HYPERCALCAEMIA 44 0.0036
160 EAR PAIN 68 0.0035
161 ARTHROPATHY 193 0.0035
162 NEUROLOGICAL DECOMPENSATION 8 0.0035
163 BACTERIAL SEPSIS 11 0.0034
164 SECOND PRIMARY MALIGNANCY 28 0.0034
165 MIGRAINE 314 0.0033
166 MYOSITIS 29 0.0032
167 ENURESIS 13 0.0032
168 PULMONARY HAEMORRHAGE 25 0.0032
169 STOMATITIS 193 0.0032
170 GASTROINTESTINAL TOXICITY 15 0.0031
171 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 53 0.0031
172 ABNORMAL UTERINE BLEEDING 8 0.0031
173 HYPERTONIC BLADDER 9 0.0031
174 MUSCULOSKELETAL PAIN 162 0.0031
175 CROHN'S DISEASE 21 0.0031
176 BICYTOPENIA 6 0.0031
177 LUNG DISORDER 150 0.0031
178 MULTI-ORGAN DISORDER 6 0.0030
179 CHAPPED LIPS 13 0.0030
180 SKIN PAPILLOMA 12 0.0030
181 REBOUND ATOPIC DERMATITIS 6 0.0030
182 INJURY 209 0.0030
183 THROMBOPHLEBITIS SUPERFICIAL 9 0.0030
184 DRUG TOLERANCE 15 0.0030
185 SPINAL FUSION SURGERY 12 0.0030
186 ULCER HAEMORRHAGE 20 0.0030
187 LONG QT SYNDROME 7 0.0029
188 TREATMENT FAILURE 240 0.0029
189 TENDERNESS 30 0.0029
190 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 7 0.0028
191 SKIN EROSION 9 0.0028
192 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 20 0.0028
193 INFUSION SITE BRUISING 6 0.0028
194 SLEEP DISORDER 195 0.0028
195 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 196 0.0028
196 HAEMORRHAGE INTRACRANIAL 41 0.0027
197 WALKING AID USER 18 0.0027
198 LOWER RESPIRATORY TRACT INFECTION 123 0.0027
199 PULMONARY FIBROSIS 51 0.0027
200 SNORING 10 0.0026
201 PRESCRIBED OVERDOSE 51 0.0026
202 TEMPOROMANDIBULAR JOINT SYNDROME 7 0.0026
203 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 10 0.0026
204 WHEEZING 155 0.0026
205 APHTHOUS STOMATITIS 6 0.0026
206 NEPHROGENIC ANAEMIA 12 0.0026
207 HEPATIC ENZYME INCREASED 176 0.0026
208 SCIATICA 41 0.0026
209 PARAESTHESIA 404 0.0026
210 DRY MOUTH 208 0.0026
211 PRURITUS GENITAL 6 0.0025
212 MACULOPATHY 9 0.0025
213 LUPUS-LIKE SYNDROME 23 0.0025
214 INFUSION RELATED REACTION 168 0.0025
215 PUSTULE 6 0.0025
216 SKIN WEEPING 9 0.0025
217 MUCOSAL INFLAMMATION 65 0.0025
218 HYPOAESTHESIA 368 0.0025
219 THROMBOCYTOSIS 9 0.0025
220 PIGMENTATION DISORDER 15 0.0024
221 PAPULE 17 0.0024
222 POTENTIATING DRUG INTERACTION 8 0.0024
223 STRIDOR 7 0.0024
224 CHEMICAL BURN OF SKIN 6 0.0024
225 ROSACEA 11 0.0024
226 MEMORY IMPAIRMENT 323 0.0023
227 EXPOSURE DURING PREGNANCY 146 0.0023
228 MEAN CELL VOLUME INCREASED 6 0.0023
229 ACNE 176 0.0023
230 EYE INJURY 7 0.0023
231 KERATITIS 7 0.0023
232 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 14 0.0023
233 PHOTOPHOBIA 43 0.0023
234 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
235 ORAL HERPES 44 0.0023
236 SKIN EXFOLIATION 189 0.0022
237 SKIN DISCOMFORT 6 0.0022
238 SWELLING 204 0.0022
239 JOINT DISLOCATION 23 0.0022
240 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0022
241 PROCTITIS 6 0.0021
242 DERMATITIS ACNEIFORM 13 0.0021
243 FACIAL PAIN 19 0.0021
244 INTENTIONAL PRODUCT USE ISSUE 186 0.0021
245 ENDOMETRIOSIS 10 0.0021
246 LOWER LIMB FRACTURE 40 0.0021
247 PRODUCT USE IN UNAPPROVED INDICATION 512 0.0021
248 BILIARY COLIC 6 0.0021
249 DISSEMINATED INTRAVASCULAR COAGULATION 29 0.0021
250 FEBRILE NEUTROPENIA 135 0.0020
251 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 111 0.0020
252 RHINITIS ALLERGIC 9 0.0020
253 DRUG-INDUCED LIVER INJURY 63 0.0020
254 MYOCARDITIS 23 0.0020
255 SLEEP APNOEA SYNDROME 38 0.0020
256 NECROTISING FASCIITIS 7 0.0020
257 GENERAL PHYSICAL HEALTH DETERIORATION 228 0.0020
258 PRODUCT QUALITY ISSUE 267 0.0020
259 RHEUMATOID ARTHRITIS 223 0.0020
260 PRODUCT COLOUR ISSUE 10 0.0019
261 HYPERAESTHESIA 16 0.0019
262 DRY SKIN 256 0.0019
263 HEPATIC CIRRHOSIS 36 0.0019
264 VAGINAL INFECTION 9 0.0019
265 POOR QUALITY PRODUCT ADMINISTERED 20 0.0019
266 FOOT DEFORMITY 21 0.0019
267 MOBILITY DECREASED 136 0.0019
268 ABDOMINAL PAIN UPPER 388 0.0019
269 PULMONARY TUBERCULOSIS 8 0.0019
270 GUILLAIN-BARRE SYNDROME 9 0.0019
271 SKIN DISORDER 62 0.0019
272 BRUXISM 10 0.0019
273 HIP ARTHROPLASTY 28 0.0018
274 MELANOCYTIC NAEVUS 8 0.0018
275 INFUSION SITE HAEMORRHAGE 6 0.0018
276 ADVERSE REACTION 24 0.0018
277 OEDEMA 98 0.0018
278 PRESCRIBED UNDERDOSE 36 0.0018
279 FOREIGN BODY IN REPRODUCTIVE TRACT 16 0.0018
280 ANHEDONIA 47 0.0018
281 THINKING ABNORMAL 33 0.0018
282 TRICUSPID VALVE INCOMPETENCE 14 0.0018
283 MATERNAL EXPOSURE BEFORE PREGNANCY 12 0.0018
284 ENDOCARDITIS 9 0.0018
285 HEPATOTOXICITY 39 0.0017
286 ELECTROCARDIOGRAM QT PROLONGED 63 0.0017
287 IMPAIRED QUALITY OF LIFE 25 0.0017
288 HYPERTRANSAMINASAEMIA 12 0.0017
289 HYPOVOLAEMIA 10 0.0017
290 POLYARTHRITIS 9 0.0017
291 SCAR 29 0.0017
292 ABORTION SPONTANEOUS 67 0.0017
293 HEAVY MENSTRUAL BLEEDING 15 0.0017
294 LEUKOCYTOSIS 30 0.0017
295 MUSCULAR WEAKNESS 188 0.0017
296 SPONDYLITIS 6 0.0016
297 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 28 0.0016
298 JOINT SWELLING 197 0.0016
299 SKIN HYPERPIGMENTATION 14 0.0016
300 LYMPHOPENIA 23 0.0016
301 DISABILITY 32 0.0016
302 EMBEDDED DEVICE 16 0.0016
303 NEURODERMATITIS 6 0.0016
304 SUNBURN 12 0.0016
305 DERMATITIS EXFOLIATIVE 8 0.0016
306 PROTEIN TOTAL DECREASED 6 0.0016
307 PERIORBITAL SWELLING 9 0.0016
308 OSTEOPENIA 24 0.0016
309 OSTEOPOROSIS 65 0.0016
310 RESPIRATORY DISORDER 47 0.0016
311 DISCOMFORT 95 0.0016
312 DEPRESSION 354 0.0016
313 SKIN IRRITATION 71 0.0015
314 APPLICATION SITE PRURITUS 35 0.0015
315 SKIN NECROSIS 8 0.0015
316 SKIN PLAQUE 13 0.0015
317 VITAMIN D DEFICIENCY 15 0.0015
318 ABDOMINAL DISCOMFORT 258 0.0015
319 HYPERTRIGLYCERIDAEMIA 9 0.0015
320 APLASTIC ANAEMIA 8 0.0015
321 DELIRIUM 53 0.0015
322 PRODUCT PREPARATION ISSUE 10 0.0015
323 ECONOMIC PROBLEM 23 0.0015
324 INTERVERTEBRAL DISC DEGENERATION 14 0.0015
325 THERAPY NON-RESPONDER 68 0.0015
326 UTERINE LEIOMYOMA 11 0.0015
327 MITRAL VALVE INCOMPETENCE 17 0.0015
328 SKIN MASS 10 0.0015
329 ANAL FISSURE 8 0.0015
330 GENERAL SYMPTOM 11 0.0015
331 ASPIRATION 16 0.0015
332 PRODUCT USE ISSUE 273 0.0015
333 HYPERKERATOSIS 8 0.0014
334 HAIR GROWTH ABNORMAL 10 0.0014
335 URTICARIA 241 0.0014
336 SKIN DISCOLOURATION 66 0.0014
337 HAEMORRHOIDS 28 0.0014
338 ORAL PAIN 32 0.0014
339 ALOPECIA 280 0.0014
340 HIDRADENITIS 13 0.0014
341 SCRATCH 15 0.0014
342 PERIPHERAL SWELLING 219 0.0014
343 CONGENITAL ANOMALY 11 0.0014
344 HEPATITIS 36 0.0014
345 DERMATITIS CONTACT 16 0.0014
346 COLITIS ULCERATIVE 62 0.0014
347 TOXIC ENCEPHALOPATHY 7 0.0014
348 LEUKAEMIA 13 0.0014
349 DIVERTICULUM INTESTINAL 6 0.0014
350 SOMNAMBULISM 9 0.0014
351 FREQUENT BOWEL MOVEMENTS 37 0.0014
352 MAJOR DEPRESSION 10 0.0014
353 PRODUCT FORMULATION ISSUE 9 0.0014
354 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
355 FEELING DRUNK 10 0.0013
356 DERMATITIS 28 0.0013
357 KNEE ARTHROPLASTY 28 0.0013
358 SENSATION OF FOREIGN BODY 11 0.0013
359 OVERWEIGHT 7 0.0013
360 GINGIVITIS 7 0.0013
361 SURGERY 76 0.0013
362 VITAMIN D DECREASED 11 0.0013
363 SUBARACHNOID HAEMORRHAGE 13 0.0013
364 DERMATITIS ATOPIC 67 0.0013
365 SKIN SWELLING 11 0.0013
366 CONTUSION 122 0.0013
367 INITIAL INSOMNIA 13 0.0013
368 CARDIAC TAMPONADE 6 0.0013
369 JOINT STIFFNESS 33 0.0013
370 NEUROTOXICITY 22 0.0013
371 TUMOUR LYSIS SYNDROME 11 0.0012
372 PREGNANCY 25 0.0012
373 SNEEZING 28 0.0012
374 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
375 PRODUCT LEAKAGE 7 0.0012
376 VULVOVAGINAL PAIN 6 0.0012
377 APPLICATION SITE RASH 17 0.0012
378 MUSCLE DISORDER 10 0.0012
379 APPLICATION SITE VESICLES 8 0.0012
380 HORMONE LEVEL ABNORMAL 6 0.0012
381 INTENTIONAL DOSE OMISSION 35 0.0012
382 APPLICATION SITE BURN 6 0.0012
383 VENOOCCLUSIVE LIVER DISEASE 6 0.0012
384 CYST 15 0.0012
385 MUSCLE SPASMS 221 0.0012
386 POST-TRAUMATIC STRESS DISORDER 8 0.0012
387 PRODUCT PRESCRIBING ISSUE 26 0.0012
388 BREAST MASS 8 0.0012
389 UPPER RESPIRATORY TRACT INFECTION 55 0.0012
390 WEIGHT INCREASED 266 0.0012
391 DRY EYE 59 0.0012
392 EYELID PTOSIS 12 0.0012
393 APPENDICITIS 11 0.0012
394 THROMBOCYTOPENIA 131 0.0012
395 CEREBRAL ISCHAEMIA 6 0.0012
396 NASOPHARYNGITIS 214 0.0012
397 PSYCHOLOGICAL TRAUMA 10 0.0012
398 HYPOALBUMINAEMIA 9 0.0012
399 CONFUSIONAL STATE 187 0.0012
400 MULTI-ORGAN FAILURE 20 0.0012
401 ROAD TRAFFIC ACCIDENT 48 0.0011
402 SKIN HAEMORRHAGE 17 0.0011
403 WEIGHT FLUCTUATION 12 0.0011
404 ERYTHEMA 235 0.0011
405 EXPIRED PRODUCT ADMINISTERED 38 0.0011
406 FUNGAL INFECTION 38 0.0011
407 APPLICATION SITE REACTION 8 0.0011
408 OFF LABEL USE 989 0.0011
409 ECZEMA 59 0.0011
410 INFUSION SITE EXTRAVASATION 7 0.0011
411 ANAL FISTULA 6 0.0011
412 RETINAL HAEMORRHAGE 8 0.0011
413 GALLBLADDER DISORDER 20 0.0011
414 HEREDITARY ANGIOEDEMA 12 0.0011
415 THERAPEUTIC RESPONSE UNEXPECTED 50 0.0011
416 PRODUCT RESIDUE PRESENT 6 0.0011
417 SINUSITIS 114 0.0011
418 MUSCULOSKELETAL STIFFNESS 97 0.0011
419 BIPOLAR DISORDER 12 0.0011
420 OVARIAN CYST 11 0.0011
421 IMPAIRED GASTRIC EMPTYING 15 0.0011
422 CONDITION AGGRAVATED 332 0.0011
423 ACUTE RESPIRATORY FAILURE 21 0.0011
424 VOMITING 510 0.0011
425 SENSITIVE SKIN 8 0.0011
426 PERICARDIAL EFFUSION 25 0.0011
427 EYE SWELLING 40 0.0011
428 ACUTE RESPIRATORY DISTRESS SYNDROME 19 0.0011
429 IMMUNODEFICIENCY 16 0.0011
430 CYTOPENIA 13 0.0011
431 GASTROINTESTINAL DISORDER 95 0.0011
432 HYPERTENSION 224 0.0011
433 PERONEAL NERVE PALSY 6 0.0011
434 FOOT FRACTURE 20 0.0011
435 COMPLICATION OF DEVICE REMOVAL 19 0.0010
436 DEEP VEIN THROMBOSIS 68 0.0010
437 FEELING HOT 64 0.0010
438 EXERCISE TOLERANCE DECREASED 6 0.0010
439 INCONTINENCE 11 0.0010
440 MADAROSIS 12 0.0010
441 EYELID OEDEMA 12 0.0010
442 RASH 448 0.0010
443 APNOEA 8 0.0010
444 AFFECTIVE DISORDER 8 0.0010
445 WHITE BLOOD CELL COUNT INCREASED 39 0.0010
446 CHRONIC KIDNEY DISEASE 77 0.0010
447 SKIN LACERATION 11 0.0010
448 INFUSION SITE PAIN 13 0.0010
449 RASH MACULAR 35 0.0010
450 ASTHMA 113 0.0010
451 LIVER DISORDER 44 0.0010
452 SEASONAL ALLERGY 14 0.0010
453 THERMAL BURN 7 0.0010
454 SINUS TACHYCARDIA 14 0.0010
455 PAIN 605 0.0010
456 AMNESIA 64 0.0010
457 EAR INFECTION 26 0.0010
458 UPPER-AIRWAY COUGH SYNDROME 8 0.0010
459 CONJUNCTIVITIS 18 0.0010
460 SCAB 11 0.0010
461 MICTURITION URGENCY 11 0.0010
462 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
463 THERAPY PARTIAL RESPONDER 15 0.0010
464 PANIC ATTACK 35 0.0010
465 LIQUID PRODUCT PHYSICAL ISSUE 7 0.0010
466 COMPLICATION OF DEVICE INSERTION 19 0.0010
467 ORAL DISORDER 7 0.0010
468 INFECTION 138 0.0010
469 COLITIS 36 0.0009
470 NEUTROPENIA 129 0.0009
471 ANXIETY 269 0.0009
472 DRUG EFFECT LESS THAN EXPECTED 14 0.0009
473 ARTHROPOD BITE 7 0.0009
474 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
475 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9 0.0009
476 PROCTALGIA 6 0.0009
477 PSEUDOMONAS INFECTION 8 0.0009
478 VISUAL IMPAIRMENT 115 0.0009
479 CARDIAC MURMUR 8 0.0009
480 BACK DISORDER 15 0.0009
481 MYOCLONUS 11 0.0009
482 SKIN BURNING SENSATION 66 0.0009
483 ABDOMINAL DISTENSION 96 0.0009
484 ASPERGILLUS INFECTION 6 0.0009
485 SKIN LESION 25 0.0009
486 PSORIASIS 119 0.0009
487 SPINAL OSTEOARTHRITIS 8 0.0009
488 ADRENAL INSUFFICIENCY 11 0.0009
489 LUNG INFILTRATION 8 0.0009
490 CONCUSSION 7 0.0009
491 HAIR TEXTURE ABNORMAL 12 0.0009
492 CARDIOTOXICITY 8 0.0009
493 PNEUMONIA 290 0.0009
494 JOINT INJURY 19 0.0009
495 EYE INFECTION 10 0.0009
496 REBOUND EFFECT 10 0.0009
497 BURNING SENSATION 62 0.0009
498 RESTLESS LEGS SYNDROME 16 0.0009
499 CARDIOMYOPATHY 13 0.0009
500 INTESTINAL OBSTRUCTION 33 0.0009
501 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 42 0.0009
502 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
503 HYPERBILIRUBINAEMIA 9 0.0009
504 HYPERSENSITIVITY 161 0.0009
505 EYE DISCHARGE 9 0.0009
506 SUICIDAL IDEATION 79 0.0009
507 FORMICATION 6 0.0009
508 POST PROCEDURAL INFECTION 7 0.0009
509 PRODUCT ODOUR ABNORMAL 9 0.0009
510 DYSPEPSIA 84 0.0009
511 HAIR DISORDER 7 0.0008
512 EMBOLISM 7 0.0008
513 PROTEINURIA 16 0.0008
514 PANCYTOPENIA 47 0.0008
515 ANKLE FRACTURE 13 0.0008
516 BONE MARROW FAILURE 17 0.0008
517 MYELOSUPPRESSION 30 0.0008
518 INFUSION SITE ERYTHEMA 7 0.0008
519 ATELECTASIS 8 0.0008
520 ARTHRALGIA 344 0.0008
521 FLUID OVERLOAD 12 0.0008
522 STAPHYLOCOCCAL INFECTION 27 0.0008
523 RASH ERYTHEMATOUS 39 0.0008
524 SMALL INTESTINAL OBSTRUCTION 10 0.0008
525 TACHYPNOEA 11 0.0008
526 HYSTERECTOMY 7 0.0008
527 SEPSIS 90 0.0008
528 HAEMATOCRIT DECREASED 16 0.0008
529 ILL-DEFINED DISORDER 49 0.0008
530 PRURITUS 309 0.0008
531 EYE PRURITUS 27 0.0008
532 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
533 RESPIRATORY DISTRESS 22 0.0008
534 HAEMORRHAGE 83 0.0008
535 PULMONARY EMBOLISM 75 0.0008
536 DEVICE RELATED INFECTION 12 0.0008
537 PRODUCT PREPARATION ERROR 16 0.0008
538 FOOD ALLERGY 6 0.0008
539 PAIN IN EXTREMITY 229 0.0008
540 EMOTIONAL DISTRESS 94 0.0008
541 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
542 PELVIC PAIN 14 0.0008
543 HYPOXIA 27 0.0008
544 EYE DISORDER 25 0.0008
545 SEPTIC SHOCK 33 0.0008
546 ATAXIA 9 0.0008
547 BACTERAEMIA 9 0.0008
548 IRON DEFICIENCY ANAEMIA 7 0.0008
549 ASTHENIA 285 0.0008
550 ADVERSE DRUG REACTION 68 0.0008
551 FURUNCLE 6 0.0008
552 RASH PRURITIC 41 0.0008
553 PRODUCT DISTRIBUTION ISSUE 7 0.0008
554 DYSMENORRHOEA 10 0.0008
555 HYPERLIPIDAEMIA 9 0.0008
556 BACTERIAL INFECTION 14 0.0007
557 ADVERSE EVENT 69 0.0007
558 FLANK PAIN 7 0.0007
559 RHINITIS 6 0.0007
560 MYASTHENIA GRAVIS 6 0.0007
561 HAEMATOTOXICITY 7 0.0007
562 INTERVERTEBRAL DISC PROTRUSION 16 0.0007
563 GASTROINTESTINAL PAIN 8 0.0007
564 PHOTOSENSITIVITY REACTION 12 0.0007
565 PHARYNGITIS 9 0.0007
566 ILEUS 9 0.0007
567 HAIR COLOUR CHANGES 9 0.0007
568 DENTAL CARIES 8 0.0007
569 TOOTH EXTRACTION 9 0.0007
570 COAGULOPATHY 12 0.0007
571 NEPHROLITHIASIS 33 0.0007
572 SECRETION DISCHARGE 9 0.0007
573 HUNGER 10 0.0007
574 SKIN FISSURES 14 0.0007
575 MALNUTRITION 8 0.0007
576 BRAIN OEDEMA 9 0.0007
577 EYE IRRITATION 41 0.0007
578 CANDIDA INFECTION 12 0.0007
579 TENDONITIS 11 0.0007
580 SKIN REACTION 10 0.0007
581 LIGAMENT SPRAIN 7 0.0007
582 MULTIPLE ORGAN DYSFUNCTION SYNDROME 20 0.0007
583 CHOLELITHIASIS 23 0.0007
584 HYPOTONIA 7 0.0007
585 PRODUCT CONTAINER ISSUE 6 0.0007
586 PYREXIA 242 0.0007
587 ASPARTATE AMINOTRANSFERASE INCREASED 37 0.0007
588 RHINORRHOEA 45 0.0007
589 NEOPLASM 8 0.0007
590 HEADACHE 436 0.0007
591 TUBULOINTERSTITIAL NEPHRITIS 13 0.0007
592 PYELONEPHRITIS 6 0.0007
593 ANAPHYLACTIC REACTION 38 0.0007
594 GASTROENTERITIS 10 0.0007
595 BLOOD ALKALINE PHOSPHATASE INCREASED 17 0.0007
596 RECTAL HAEMORRHAGE 29 0.0007
597 EYE HAEMORRHAGE 9 0.0007
598 EYE PAIN 38 0.0007
599 RASH PAPULAR 15 0.0007
600 PAIN OF SKIN 18 0.0007
601 BLOOD BILIRUBIN INCREASED 18 0.0007
602 SINUS CONGESTION 9 0.0007
603 DIZZINESS 332 0.0007
604 BONE LOSS 10 0.0007
605 GASTROENTERITIS VIRAL 12 0.0007
606 DRUG RESISTANCE 17 0.0007
607 ANAEMIA 126 0.0007
608 NOCTURIA 8 0.0007
609 RESPIRATORY FAILURE 48 0.0007
610 ABDOMINAL PAIN 153 0.0007
611 INSOMNIA 175 0.0007
612 OEDEMA PERIPHERAL 80 0.0007
613 PERIPHERAL COLDNESS 9 0.0007
614 IMPAIRED WORK ABILITY 14 0.0007
615 INSURANCE ISSUE 10 0.0007
616 INJECTION SITE URTICARIA 16 0.0007
617 INCREASED TENDENCY TO BRUISE 6 0.0007
618 MUSCLE SPASTICITY 8 0.0007
619 DRUG INEFFECTIVE 858 0.0007
620 UROSEPSIS 6 0.0006
621 POOR QUALITY SLEEP 14 0.0006
622 BRONCHITIS 48 0.0006
623 PULMONARY OEDEMA 29 0.0006
624 DIARRHOEA 418 0.0006
625 MUSCULOSKELETAL CHEST PAIN 10 0.0006
626 COORDINATION ABNORMAL 9 0.0006
627 DEVICE DISLOCATION 28 0.0006
628 MASS 9 0.0006
629 EJECTION FRACTION DECREASED 10 0.0006
630 CEREBRAL HAEMORRHAGE 23 0.0006
631 BONE DENSITY DECREASED 20 0.0006
632 BRAIN FOG 10 0.0006
633 LACERATION 6 0.0006
634 PRODUCT DOSE OMISSION IN ERROR 18 0.0006
635 UNEVALUABLE EVENT 48 0.0006
636 VENTRICULAR FIBRILLATION 7 0.0006
637 INJECTION SITE IRRITATION 8 0.0006
638 LIMB INJURY 17 0.0006
639 PRODUCT SUBSTITUTION ISSUE 36 0.0006
640 PLEURAL EFFUSION 38 0.0006
641 PARAESTHESIA ORAL 9 0.0006
642 LYMPHOCYTE COUNT DECREASED 11 0.0006
643 ANOSMIA 9 0.0006
644 DECREASED APPETITE 144 0.0006
645 LEUKOPENIA 31 0.0006
646 INTERSTITIAL LUNG DISEASE 30 0.0006
647 DIPLOPIA 16 0.0006
648 PLATELET COUNT INCREASED 8 0.0006
649 PRODUCT DOSE OMISSION ISSUE 180 0.0006
650 HEPATOMEGALY 6 0.0006
651 INJECTION SITE REACTION 42 0.0006
652 FLUID RETENTION 31 0.0006
653 HYPOKALAEMIA 28 0.0006
654 MYALGIA 103 0.0006
655 DRUG INTERACTION 96 0.0006
656 ILLNESS 62 0.0006
657 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
658 CLOSTRIDIUM DIFFICILE INFECTION 13 0.0006
659 THERAPEUTIC RESPONSE DECREASED 36 0.0006
660 PRODUCT ADMINISTRATION ERROR 12 0.0006
661 THROAT TIGHTNESS 16 0.0006
662 DEVICE BREAKAGE 24 0.0006
663 OCULAR HYPERAEMIA 28 0.0006
664 TOOTH ABSCESS 6 0.0006
665 MIDDLE INSOMNIA 11 0.0006
666 DRUG EXPOSURE DURING PREGNANCY 20 0.0006
667 CHOLECYSTITIS 7 0.0006
668 TREATMENT NONCOMPLIANCE 32 0.0006
669 EAR DISCOMFORT 6 0.0006
670 CHEST PAIN 108 0.0006
671 ACUTE KIDNEY INJURY 89 0.0006
672 TEMPERATURE INTOLERANCE 6 0.0006
673 ACUTE MYOCARDIAL INFARCTION 17 0.0006
674 CHROMATURIA 13 0.0006
675 NAUSEA 454 0.0006
676 GASTRITIS 15 0.0006
677 DRUG ADMINISTERED AT INAPPROPRIATE SITE 6 0.0006
678 SWELLING FACE 37 0.0006
679 NEUROPATHY PERIPHERAL 54 0.0006
680 PANCREATITIS 30 0.0006
681 HEAD DISCOMFORT 10 0.0006
682 HYPOTHYROIDISM 18 0.0006
683 BODY HEIGHT DECREASED 6 0.0006
684 THIRST 10 0.0006
685 DYSPHAGIA 53 0.0006
686 CARDIOGENIC SHOCK 8 0.0006
687 DERMATITIS ALLERGIC 7 0.0006
688 CELLULITIS 28 0.0006
689 ACTIVITIES OF DAILY LIVING IMPAIRED 11 0.0006
690 BACK PAIN 129 0.0006
691 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
692 BLOOD PRESSURE ABNORMAL 11 0.0006
693 TOOTHACHE 10 0.0006
694 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
695 RENAL FAILURE 73 0.0005
696 GAIT DISTURBANCE 105 0.0005
697 END STAGE RENAL DISEASE 10 0.0005
698 ROTATOR CUFF SYNDROME 7 0.0005
699 VENTRICULAR TACHYCARDIA 9 0.0005
700 HALLUCINATION 41 0.0005
701 GENERALISED TONIC-CLONIC SEIZURE 9 0.0005
702 LABORATORY TEST ABNORMAL 16 0.0005
703 EXPOSURE VIA SKIN CONTACT 14 0.0005
704 TOOTH DISORDER 12 0.0005
705 RESPIRATORY TRACT INFECTION 14 0.0005
706 NODULE 7 0.0005
707 PANCREATITIS ACUTE 12 0.0005
708 HEART RATE IRREGULAR 12 0.0005
709 ABORTION INDUCED 5 0.0005
710 PULMONARY CONGESTION 7 0.0005
711 SARS-COV-2 TEST POSITIVE 7 0.0005
712 LACRIMATION INCREASED 16 0.0005
713 PAIN IN JAW 15 0.0005
714 BONE PAIN 31 0.0005
715 CHILLS 62 0.0005
716 VERTIGO 32 0.0005
717 LOSS OF CONSCIOUSNESS 67 0.0005
718 QUALITY OF LIFE DECREASED 7 0.0005
719 MEDICATION ERROR 29 0.0005
720 HALLUCINATION, VISUAL 11 0.0005
721 WEIGHT DECREASED 145 0.0005
722 RENAL FAILURE ACUTE 22 0.0005
723 VASCULITIS 6 0.0005
724 BASAL CELL CARCINOMA 8 0.0005
725 PALPITATIONS 60 0.0005
726 DRUG ERUPTION 9 0.0005
727 TACHYCARDIA 45 0.0005
728 SINUS DISORDER 10 0.0005
729 RESPIRATORY TRACT CONGESTION 8 0.0005
730 APHASIA 15 0.0005
731 TRANSAMINASES INCREASED 11 0.0005
732 RASH MACULO-PAPULAR 11 0.0005
733 MUSCLE TIGHTNESS 8 0.0005
734 NEURALGIA 12 0.0005
735 ALANINE AMINOTRANSFERASE INCREASED 30 0.0005
736 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
737 CARDIOMEGALY 6 0.0005
738 FATIGUE 379 0.0005
739 OSTEONECROSIS OF JAW 12 0.0005
740 THERAPEUTIC RESPONSE SHORTENED 16 0.0005
741 VIRAL INFECTION 16 0.0005
742 LIP SWELLING 16 0.0005
743 APATHY 7 0.0005
744 UNDERDOSE 35 0.0005
745 DISORIENTATION 19 0.0005
746 MUSCLE TWITCHING 11 0.0005
747 OROPHARYNGEAL PAIN 44 0.0005
748 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 85 0.0005
749 RENAL INJURY 14 0.0005
750 INTRAOCULAR PRESSURE INCREASED 6 0.0005
751 DIVERTICULITIS 13 0.0005
752 MYDRIASIS 6 0.0005
753 ANOREXIA 6 0.0005
754 DISTURBANCE IN ATTENTION 25 0.0005
755 CONSTIPATION 101 0.0005
756 VAGINAL HAEMORRHAGE 20 0.0005
757 NASAL CONGESTION 27 0.0005
758 TINNITUS 21 0.0005
759 INJECTION SITE RASH 14 0.0005
760 LOCALISED INFECTION 11 0.0005
761 RED BLOOD CELL COUNT DECREASED 13 0.0005
762 HYPERSOMNIA 13 0.0005
763 DYSSTASIA 13 0.0004
764 BLOOD CREATININE INCREASED 29 0.0004
765 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
766 PNEUMOTHORAX 7 0.0004
767 ULCER 7 0.0004
768 DYSPNOEA 249 0.0004
769 GINGIVAL BLEEDING 6 0.0004
770 HYPERGLYCAEMIA 16 0.0004
771 ACUTE HEPATIC FAILURE 6 0.0004
772 VISION BLURRED 60 0.0004
773 HIP FRACTURE 14 0.0004
774 ABDOMINAL PAIN LOWER 11 0.0004
775 TOOTH LOSS 9 0.0004
776 HEART RATE INCREASED 43 0.0004
777 BLOOD POTASSIUM DECREASED 13 0.0004
778 ARTHRITIS 34 0.0004
779 POLLAKIURIA 18 0.0004
780 HYPOMAGNESAEMIA 6 0.0004
781 SUICIDE ATTEMPT 26 0.0004
782 SEIZURE 49 0.0004
783 FRACTURE 8 0.0004
784 EMOTIONAL DISORDER 13 0.0004
785 GASTRIC ULCER 8 0.0004
786 MUSCULOSKELETAL DISORDER 8 0.0004
787 PRODUCT PRESCRIBING ERROR 10 0.0004
788 BLOOD UREA INCREASED 7 0.0004
789 NEUTROPHIL COUNT DECREASED 17 0.0004
790 PRODUCT DISPENSING ERROR 9 0.0004
791 SYNCOPE 41 0.0004
792 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 12 0.0004
793 CEREBRAL INFARCTION 10 0.0004
794 MUSCULOSKELETAL DISCOMFORT 7 0.0004
795 INJECTION SITE PRURITUS 27 0.0004
796 PULMONARY MASS 6 0.0004
797 EPISTAXIS 30 0.0004
798 INTENTIONAL PRODUCT MISUSE 35 0.0004
799 AMENORRHOEA 7 0.0004
800 URINARY TRACT INFECTION 68 0.0004
801 ABNORMAL DREAMS 11 0.0004
802 LYMPHADENOPATHY 14 0.0004
803 DEVICE FAILURE 6 0.0004
804 ISCHAEMIC STROKE 7 0.0004
805 SHOCK 9 0.0004
806 MENTAL DISORDER 17 0.0004
807 GOUT 7 0.0004
808 THERAPY CESSATION 20 0.0004
809 RIB FRACTURE 8 0.0004
810 ACCIDENTAL EXPOSURE TO PRODUCT 40 0.0004
811 OSTEOMYELITIS 7 0.0004
812 FALL 128 0.0004
813 SOMNOLENCE 77 0.0004
814 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 7 0.0004
815 PRODUCT USE COMPLAINT 6 0.0004
816 MOUTH ULCERATION 8 0.0004
817 HEAD INJURY 12 0.0004
818 DISEASE RECURRENCE 18 0.0004
819 DEPRESSED MOOD 20 0.0004
820 PREMATURE DELIVERY 6 0.0004
821 SENSORY DISTURBANCE 6 0.0004
822 BLOOD SODIUM DECREASED 7 0.0004
823 MENTAL IMPAIRMENT 9 0.0004
824 FOETAL EXPOSURE DURING PREGNANCY 30 0.0004
825 RENAL IMPAIRMENT 31 0.0004
826 INJECTION SITE SWELLING 28 0.0004
827 MULTIPLE FRACTURES 6 0.0004
828 COGNITIVE DISORDER 17 0.0004
829 THERAPY INTERRUPTED 26 0.0004
830 HAEMATOCHEZIA 20 0.0004
831 PROCEDURAL PAIN 10 0.0004
832 STEVENS-JOHNSON SYNDROME 8 0.0004
833 WHITE BLOOD CELL COUNT DECREASED 39 0.0004
834 BLOOD PRESSURE INCREASED 55 0.0004
835 COVID-19 63 0.0004
836 FEELING ABNORMAL 86 0.0004
837 MENORRHAGIA 7 0.0004
838 OXYGEN SATURATION DECREASED 20 0.0004
839 FACE OEDEMA 6 0.0004
840 ACCIDENTAL OVERDOSE 13 0.0004
841 RESTLESSNESS 13 0.0004
842 FLUSHING 36 0.0004
843 SWOLLEN TONGUE 11 0.0004
844 HYPOPHAGIA 9 0.0004
845 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25 0.0004
846 SPINAL FRACTURE 7 0.0003
847 NIGHTMARE 12 0.0003
848 MALAISE 152 0.0003
849 ORTHOSTATIC HYPOTENSION 6 0.0003
850 METABOLIC ACIDOSIS 11 0.0003
851 SPEECH DISORDER 18 0.0003
852 TREMOR 57 0.0003
853 DEVICE USE ISSUE 6 0.0003
854 CHEST DISCOMFORT 35 0.0003
855 HYPERHIDROSIS 44 0.0003
856 HOSPITALISATION 52 0.0003
857 ARRHYTHMIA 16 0.0003
858 CARDIAC FAILURE CONGESTIVE 27 0.0003
859 PULMONARY HYPERTENSION 7 0.0003
860 INJECTION SITE PAIN 103 0.0003
861 OSTEONECROSIS 11 0.0003
862 IRRITABILITY 20 0.0003
863 CRYING 12 0.0003
864 MOOD ALTERED 9 0.0003
865 BONE DISORDER 6 0.0003
866 EATING DISORDER 7 0.0003
867 HYPOTENSION 65 0.0003
868 DEVICE EXPULSION 21 0.0003
869 LIMB DISCOMFORT 10 0.0003
870 HAEMOPTYSIS 9 0.0003
871 HAEMOGLOBIN DECREASED 33 0.0003
872 HAEMATURIA 11 0.0003
873 NERVOUS SYSTEM DISORDER 10 0.0003
874 INCORRECT DRUG ADMINISTRATION DURATION 9 0.0003
875 DYSPNOEA EXERTIONAL 12 0.0003
876 COUGH 89 0.0003
877 HYPOCALCAEMIA 6 0.0003
878 INFLUENZA LIKE ILLNESS 26 0.0003
879 CARDIAC ARREST 26 0.0003
880 FEELING JITTERY 6 0.0003
881 AGITATION 23 0.0003
882 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0003
883 THROMBOSIS 25 0.0003
884 DYSPHONIA 18 0.0003
885 SEDATION 8 0.0003
886 DISEASE PROGRESSION 36 0.0003
887 URINARY INCONTINENCE 9 0.0003
888 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
889 BLOOD PRESSURE DECREASED 20 0.0003
890 RENAL DISORDER 14 0.0003
891 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
892 CARDIAC FAILURE 24 0.0003
893 MENSTRUATION IRREGULAR 8 0.0003
894 INJECTION SITE ERYTHEMA 37 0.0003
895 FEAR 8 0.0003
896 PRODUCT PHYSICAL ISSUE 6 0.0003
897 FEEDING DISORDER 6 0.0003
898 HEPATIC FUNCTION ABNORMAL 11 0.0003
899 PALLOR 8 0.0003
900 NO ADVERSE EVENT 53 0.0003
901 DYSARTHRIA 11 0.0003
902 INJECTION SITE BRUISING 23 0.0003
903 ATRIAL FIBRILLATION 28 0.0003
904 INFLUENZA 32 0.0003
905 DEHYDRATION 38 0.0003
906 RETCHING 6 0.0003
907 CONVULSION 16 0.0003
908 HOT FLUSH 21 0.0003
909 HERPES ZOSTER 16 0.0003
910 LETHARGY 16 0.0003
911 BALANCE DISORDER 24 0.0003
912 ERECTILE DYSFUNCTION 7 0.0003
913 PLATELET COUNT DECREASED 29 0.0003
914 DYSURIA 10 0.0003
915 ANAPHYLACTIC SHOCK 7 0.0003
916 PSYCHOTIC DISORDER 8 0.0003
917 SKIN ULCER 7 0.0003
918 INJECTION SITE MASS 10 0.0003
919 HAEMATOMA 7 0.0003
920 CATARACT 16 0.0003
921 DEAFNESS 7 0.0003
922 DEVICE ISSUE 24 0.0003
923 HEPATIC FAILURE 8 0.0003
924 JAUNDICE 7 0.0003
925 PNEUMONITIS 7 0.0003
926 HYPERKALAEMIA 9 0.0003
927 PRODUCTIVE COUGH 12 0.0003
928 CYSTITIS 8 0.0003
929 MOOD SWINGS 8 0.0003
930 MULTIPLE SCLEROSIS 12 0.0003
931 DIABETES MELLITUS 19 0.0002
932 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
933 ANGIOEDEMA 11 0.0002
934 THROAT IRRITATION 11 0.0002
935 PRODUCT DOSE OMISSION 16 0.0002
936 DRUG EFFECT DECREASED 13 0.0002
937 VISUAL ACUITY REDUCED 8 0.0002
938 AGEUSIA 6 0.0002
939 URINARY RETENTION 8 0.0002
940 ASCITES 7 0.0002
941 CARDIOVASCULAR DISORDER 6 0.0002
942 HYPOACUSIS 10 0.0002
943 PHARMACEUTICAL PRODUCT COMPLAINT 6 0.0002
944 COMA 11 0.0002
945 FLATULENCE 13 0.0002
946 PRODUCT STORAGE ERROR 20 0.0002
947 HYPOGLYCAEMIA 11 0.0002
948 EXTRA DOSE ADMINISTERED 9 0.0002
949 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
950 RESPIRATORY ARREST 6 0.0002
951 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 44 0.0002
952 MENTAL STATUS CHANGES 6 0.0002
953 RHABDOMYOLYSIS 9 0.0002
954 MALIGNANT NEOPLASM PROGRESSION 22 0.0002
955 WITHDRAWAL SYNDROME 9 0.0002
956 OVERDOSE 45 0.0002
957 LIVER FUNCTION TEST ABNORMAL 6 0.0002
958 GASTRIC DISORDER 7 0.0002
959 GASTROINTESTINAL HAEMORRHAGE 17 0.0002
960 ABASIA 5 0.0002
961 HEART RATE DECREASED 7 0.0002
962 BLINDNESS 8 0.0002
963 FEMUR FRACTURE 6 0.0002
964 CARDIO-RESPIRATORY ARREST 8 0.0002
965 MOVEMENT DISORDER 6 0.0002
966 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
967 CEREBROVASCULAR ACCIDENT 30 0.0002
968 ABNORMAL BEHAVIOUR 7 0.0002
969 INCORRECT DOSE ADMINISTERED 40 0.0002
970 NERVOUSNESS 9 0.0002
971 DRUG EFFECT INCOMPLETE 6 0.0002
972 DRUG DOSE OMISSION 27 0.0002
973 TOXICITY TO VARIOUS AGENTS 27 0.0002
974 INJECTION SITE HAEMORRHAGE 12 0.0002
975 DYSKINESIA 6 0.0001
976 BLOOD GLUCOSE DECREASED 7 0.0001
977 MYOCARDIAL INFARCTION 24 0.0001
978 DYSGEUSIA 10 0.0001
979 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
980 DEATH 111 0.0001
981 CARDIAC DISORDER 12 0.0001
982 DEVICE MALFUNCTION 9 0.0001
983 BLOOD GLUCOSE INCREASED 22 0.0001
984 NEOPLASM MALIGNANT 6 0.0001
985 BREAST CANCER 8 0.0001
986 COMPLETED SUICIDE 6 0.0001
987 DRUG WITHDRAWAL SYNDROME 6 0.0001
988 DRUG DEPENDENCE 9 0.0001